【新唐人2013年06月26日讯】近年来，中国各地频频发生大规模“疫苗事故”，引起舆论聚焦。据统计，中国每年疫苗预防接种次数达到10亿，即使按照中共声称的疫苗不良反应百万分之一到二的概率，每年也有超过1千个孩子会留下后遗症。有疫苗专家认为，这是最保守的数字，每年疫苗致残案例远不止这个数字。另有专家指出，中国很多疫苗还在使用60年代的技术。
中国《南方都市报》日前刊发八整版，图文并茂的调查报告——“疫苗之殇”，其中，记录了50个孩子被劣质国产疫苗致残、致死的案例。并且披露了造成这些悲剧的原因，主要是生产管理落后、垄断经营、缺乏监管及官员腐败等。
据中共当局统计，中国每年疫苗预防接种剂次达10亿。报导说，即使按照中国疾控中心主任王宇公布的“疫苗不良反应概率”是百万分之一到二，那也表示，中国每年有超过1000个孩子，患上各种疫苗后遗症，留下终身残疾。
“山西省疾控中心信息管理科”原科长陈涛安，在接受《新唐人》采访时指出，官方公布的概率，是最保守的数字。他说，每年疫苗致残案例远不止这个数。
山西省疾控中心信息管理科原科长陈涛安：“因为你只是说，在厂家疫苗的这种科学管理下的前提下这么多，但是，我们目前的科学管理还达不到，疫苗的存储、运输和销售各方面的管理上，还有很多漏洞，这些漏洞会导致异常反应概率进一步提高。”
报导说，中国开发的疫苗品种多为单价疫苗、减毒活疫苗等传统疫苗品种，而国外上市的疫苗多以新型疫苗为主，国产疫苗在产能和关键技术上与国际先进水平相差巨大。
2010年3月，中国疾控中心主任王宇已经指出，“有些（国产）疫苗的质量，在大规模人群始用中，完全达不到我们现在需要的质量标准”他还表示，监管部门缺少对这些疫苗大规模上市后的系统评价。与进口疫苗相比，质量档次差很多。
陈涛安说，中国的很多疫苗还在使用西方国家已经淘汰了很多年的技术。“北京大学医学部”免疫学系副主任王月丹指出：很多疫苗使用的还是60年代的技术。
陈涛安分析，造成中国疫苗技术严重落后的主要原因，是国家的垄断和权大于法。他说，国内的一类疫苗市场，都被官方的6大生物制品研究所、和中国生物技术集团公司垄断，而且每年招标、投标都是这几个部门的官员坐下来分配利益，定下价格，按订单生产，根本谈不上优胜劣败。
陈涛安：“我们国家有反不正当的竞争法、有反垄断法，你这么多法它不依，它是权大于法，都是这个原因造成的，保护垄断压制住技术的发展了，你把垄断打破了，它技术必然就会发展，不发展它没法生存。”
陈涛安指出，其中官商勾结、黑市交易、政府失职等问题也不堪设想，但却是中国人不得不面对的事实。
陈涛安：“一些疫苗不法商人，可以从官方的厂家中买出疫苗来，这黑市买卖，就会导致疫苗在存储、运输链条上的风险进一步加大。（官方）为了保护某一批人，说疫苗存储环境不好也是合格的，官方出来这样的定义以后，那就导致存储、运输环境、生态环境的恶化。”
陈涛安指出，除去冷冻、运输、保存等环节上的隐患，疫苗本身也是高风险的生物制品，再好的疫苗都会有异常反应的概率。
近年来，大批疫苗受害儿家长走上了艰难的维权之路，但是能得到国家赔偿者却寥寥无几。此外，这几年曝光的江苏宿迁假疫苗案、和大连金港安迪的疫苗违法添加事件、江苏延申疫苗造假事件，以及，去年山东涉及全国的非法疫苗案都没有得到真正的解决。
采访/林莉 编辑/李韵 后制/王明宇
Adverse Reactions to Vaccines in China
In recent years, the frequent occurrence of vaccine accidents all over China have become a public focus. According to statistics, China’s annual vaccination number reached 1 billion, even with the Chinese Communist Party (CCP) claims that adverse reactions are a one or two in a million probability, every year more than one thousand children will have sequelae. Vaccine experts believe this is a most conservative figure. There were many more annual vaccine disability cases than this figure accounts for. Another expert pointed out that in China, many vaccines still use 1960’s technology.
Nanfang Urban Newspaper recently published eight full pages of a survey report —— Vaccine War – due to inferior domestic vaccines. It also disclosed the reasons behind these tragedies —— poor management, monopolies, lack of regulation and official corruption.
According to Chinese authorities’ statistics, China’s annual vaccination doses were up to one billion. It is reported that, even with the vaccine adverse reaction claim being a one or two in a millionth probability, as announced by CDC Director Wang Yu, there are more than 1,000 children suffering from a variety of vaccine complications each year in China, leaving life-long disability.
Former chief of Shanxi CDC Information Management Division, Chen Taoan told NTD that the official announced probability is a very conservative figure. He said that the annual vaccine disability cases were far more than this.
Chen Taoan: “Many premises in the scientific management of the vaccine had not yet been reached. In vaccine storage, transportation, marketing and all aspects of management, there are many loopholes, which lead to further increase the probability of an abnormal reaction."
It is reported that vaccine varieties developed in China are monovalent vaccines, live attenuated vaccines and other traditional vaccines varieties, while in the foreign market it is mainly new vaccines. Domestic vaccine production capacity and key technologies are so far away from the international advanced level.
In March 2010, China CDC Director Wang Yu pointed out that, “The quality of some (domestic) vaccines could not fully reach the standards we need to use now on a large population." He said, systematic reviews are lacking after the listing of these vaccines for the regulatory authorities. Compared with imported vaccines, quality and grades are poor.
Chen Taoan said that China’s vaccines are still being created using techniques which have been eliminated for many years in western world. Wang Yuedan, deputy director of the Department of Immunology in Peking University, said many vaccines are still created using 1960’s technology.
Chen Taoan analyzed that the main reason Chinese vaccine technology is seriously lagging behind is because, in China, the power is above the law. He said that the Class I domestic vaccine market has been monopolized by the six major official Institutes of Biological Products and China National Biotec Corporation, and every year these officials sit down to divide benefits, set prices, and produce according to orders. They play survival of the fittest.
Chen Taoan: “There are anti-unfair competition laws, antitrust laws in China, but they are not followed. This shows that power is above laws.
Protection of the monopoly suppresses the development of technology. If you break the monopoly, technologies will inevitably develop, or else it cannot survive."
Chen Taoan pointed out that collusion of officials and businesses, the black market, state failure and other issues are in a critical situation, but it is the Chinese people who have to face it.
Chen Taoan: “Some unscrupulous vaccine traders buy from the official vaccine manufacturer, and sell on the black market, which increases risks in vaccine storage and transportation. (Officials), in order to protect vested interests, say the vaccine is under qualified storage. Such an official definitions led to deterioration of storage, transportation and ecological environment."
Chen Taoan pointed out that except frozen, transport, storage and other aspects of risks, the vaccine itself is also a high risk of biological products, all vaccines will have a probability of abnormal reactions.
In recent years, a large number of parents of vaccine-injured children embarked on the difficult road for human rights, but few can get state compensation. In addition, in recent years, no vaccine cases were solved, including the fake vaccine cases in Suqian, Jiangsu Province, the illegal addition of vaccines in Jingang, Dalian, the vaccine fraud case in Yanshen, Jiangsu Province, as well as illegal vaccine cases in Shandong involving the country.
